| P50 | author | Grace Lai-Hung Wong | Q38136022 |
| P2860 | cites work | Liver biopsy | Q83395480 |
| | Screening the general population for cirrhosis using transient elastography: finding a needle in a haystack? | Q83798986 |
| | Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases | Q83843071 |
| | Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B | Q83868014 |
| | Hepatic amyloidosis increases liver stiffness measured by transient elastography | Q84200656 |
| | Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography | Q84308242 |
| | Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years | Q84484058 |
| | Noninvasive assessment of liver fibrosis via spleen stiffness measurement using acoustic radiation force impulse sonoelastography in patients with chronic hepatitis B or C | Q84729037 |
| | Feasibility study and control values of transient elastography in healthy children | Q84809394 |
| | Association between anthropometric parameters and measurements of liver stiffness by transient elastography | Q87396182 |
| | Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease | Q87406034 |
| | Quantifying hepatic shear modulus in vivo using acoustic radiation force | Q24649957 |
| | Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study | Q24680285 |
| | Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity | Q28297290 |
| | Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults | Q29614911 |
| | Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity | Q29614932 |
| | EASL clinical practice guidelines: Management of chronic hepatitis B virus infection | Q29615868 |
| | Chronic hepatitis B: update 2009 | Q29617409 |
| | Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores | Q30465393 |
| | Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. | Q31040495 |
| | Liver biopsy | Q33932981 |
| | Outcome of patients hospitalized for complications after outpatient liver biopsy | Q34358895 |
| | Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. | Q34390093 |
| | Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. | Q34544284 |
| | Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. | Q34585594 |
| | Performance of transient elastography for the staging of liver fibrosis: a meta-analysis | Q34590187 |
| | Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. | Q35598407 |
| | Review article: the evolving role of liver biopsy | Q35845834 |
| | Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease | Q36014015 |
| | Nonalcoholic fatty liver disease: from steatosis to cirrhosis | Q36382279 |
| | Noninvasive measures of liver fibrosis | Q36382285 |
| | Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others. | Q36838605 |
| | Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis | Q36960779 |
| | Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update | Q37278241 |
| | The clinical use of HVPG measurements in chronic liver disease | Q37590666 |
| | Transient elastography | Q37805637 |
| | Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies? | Q37863142 |
| | The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan | Q37932842 |
| | Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods. | Q38070696 |
| | Clinical hepatology: profile of an urban, hospital-based practice | Q39432473 |
| | Acute viral hepatitis increases liver stiffness values measured by transient elastography | Q40141905 |
| | Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model | Q40441364 |
| | An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis | Q41970506 |
| | Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). | Q42410021 |
| | Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. | Q43041031 |
| | Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices | Q79781279 |
| | Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation | Q79846807 |
| | Transient elastography: a valid alternative to biopsy in patients with chronic liver disease | Q80054977 |
| | Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage | Q80245191 |
| | Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation | Q80546480 |
| | Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis | Q82214451 |
| | Liver stiffness is directly influenced by central venous pressure | Q82292984 |
| | Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease | Q82648058 |
| | Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan® | Q82980218 |
| | Clinical predictors of fibrosis in patients with chronic liver disease | Q82996174 |
| | Head-to-head comparison of transient elastography (TE), real-time tissue elastography (RTE), and acoustic radiation force impulse (ARFI) imaging in the diagnosis of liver fibrosis | Q83186401 |
| | Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population | Q83284546 |
| | Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. | Q43047842 |
| | Feasibility of liver transient elastography with FibroScan using a new probe for obese patients | Q43056991 |
| | Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C. | Q43126256 |
| | Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B. | Q43151663 |
| | Intracholecystic hemorrhage: an atypical complication after liver needle biopsy | Q43556291 |
| | Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese | Q43662697 |
| | Liver stiffness measurement by transient elastography as a predictor on posthepatectomy outcomes | Q43682657 |
| | Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. | Q43875619 |
| | Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease | Q44022305 |
| | Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis | Q44087737 |
| | Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model | Q44151781 |
| | Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection | Q44464287 |
| | A 21-year experience with major hemorrhage after percutaneous liver biopsy | Q44773944 |
| | Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years | Q45161999 |
| | Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease | Q45346653 |
| | Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). | Q45369097 |
| | Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection | Q45381693 |
| | The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. | Q45400018 |
| | Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients | Q45421063 |
| | Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. | Q45752530 |
| | Spleen stiffness: toward a noninvasive portal sphygmomanometer? | Q46014287 |
| | Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations | Q46078112 |
| | Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores | Q46242740 |
| | Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. | Q46450252 |
| | Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. | Q46611928 |
| | Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®). | Q47428102 |
| | Sampling variability of liver fibrosis in chronic hepatitis C. | Q48583601 |
| | "Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country. | Q51005393 |
| | Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. | Q51545030 |
| | On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. | Q51584406 |
| | Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. | Q51655382 |
| | Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. | Q51830742 |
| | Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. | Q53039947 |
| | Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. | Q53711274 |
| | Liver fibrosis in patients with chronic hepatitis C: noninvasive diagnosis by means of real-time tissue elastography--establishment of the method for measurement. | Q54431481 |
| | Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis | Q54513263 |
| | Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis | Q56980632 |
| | Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography | Q57735439 |
| | Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B | Q57782726 |
| | Liver biopsy: The best standard…when everything else fails | Q58622680 |
| | Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency | Q58622695 |
| | Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability | Q58622704 |
| | Determination of reliability criteria for liver stiffness evaluation by transient elastography | Q59352739 |
| | Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases | Q61054091 |
| | Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography | Q61567953 |
| | Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C | Q61763020 |
| | Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis | Q61763027 |
| | Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C | Q61764154 |
| | Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease | Q61764171 |
| | Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study | Q63434832 |
| | Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies | Q70032258 |
| P433 | issue | 5 | |
| P304 | page(s) | 264-274 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | World Journal of Hepatology | Q27723328 |
| P1476 | title | Transient elastography: Kill two birds with one stone? | |
| P478 | volume | 5 | |